Radiation Oncology

The Department of Radiation Oncology at Washington University is dedicated to excellence in patient care, teaching and research. The department is one of the largest in the United States and a national leader in developing the most recent radiation treatments for cancer patients. Our physicians are committed to patients in all aspects of care

Text Size: S M L

Home > Physicians Directory > Radiation Oncology

Jeff Michael Michalski, MD, MBA

Specialty Areas
Radiation Oncology
Sarcoma
Genitourinary Oncology
Pediatric Oncology

See additional features on Dr Michalski

From the Record, 11/23/2009

From Ladue News Ask the Expert, June 2009


Areas of Clinical Interest
Radiation therapy, radiation oncology, pediatric oncology, prostate conditions, prostate cancer, treatment planning, carcinoma of the prostate, conformal radiation therapy, prostate brachytherapy

Major or Recent Publications/Awards

Honors and Awards

Listed in Best Doctors in America, 2003 - 2009 (Best Doctors, Inc)

Listed in America's Top Doctors, Castle Connolly Medical Ltd, 2005 - 2009

American College of Radiology Fellowship, 2003

Editorial Responsibilities

Seminars in Radiation Oncology, Guest Editor, 2002

International Journal of Radiation Oncology Biology, Physics, Editorial Board, 1998

Radiologic Society of North America, Education Committee, Reviewer, 1998

Selected Recent Journal Articles

Michalski JM, Meza J, Breneman JC, Wolden SL, Laurie F, Jodoin MA, Raney B, Wharam M, Donaldson SS. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group Trials II through IV. Int J Radiat Oncol Biol Phys 2004; 59(4), 1027-103

Michalski JM, Winter K, Purdy J, Perez CA, et al. Toxicity following 3D radiation therapy for prostate cancer on RTOG 9406 dose level IV. Int J Radiat Oncol Biol Phys, 2004; 58(3), 835-742

Chapman JD, Bradley JD, Eary JF, Haubner R, Larson SM, Michalski JM, Okunieff PG, Strauss HW, Ung YC, Welch MJ. Molecular (Functional) imaging for radiotherapy applications: An RTOG symposium. Int J Radiat Oncol Biol Phys 55(2)2003; 294-301

Michalski JM, Bae K, Roach M, Markoe AM, Sandler HM, Ryu J, Parliament MB, Straube W, Valicenti RK, Cox JD. Long-Term Toxicity Following 3D Conformal Radiation Therapy for Prostate Cancer from the RTOG 9406 Phase I/II Dose Escalation Study. Int J Radiat Oncol Biol Phys. 2009 Jul 3. [Epub ahead of print]

Michalski JM, Bosch WR, Purdy JA.Clinical trials and radiation oncology technologies.Oncology (Williston Park). 2009 Apr 15;23(4):386, 389.

Michalski JM, Lawton C, El Naqa I, Ritter M, O'Meara E, Seider MJ, Lee WR, Rosenthal SA, Pisansky T, Catton C, Valicenti RK, Zietman AL, Bosch WR, Sandler H, Buyyounouski MK, Ménard C. Development of RTOG Consensus Guidelines for the Definition of the Clinical Target Volume for Postoperative Conformal Radiation Therapy for Prostate Cancer.Int J Radiat Oncol Biol Phys. 2009 Apr 23. [Epub ahead of print]

Michalski JM, Roach M 3rd, Merrick G, Anscher MS, Beyer DC, Lawton CA, Lee WR, Pollack A, Rosenthal SA, Vijayakumar S, Carroll PR. ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):667-72. Epub 2009 Apr 20.

Rosenthal SA, Bae K, Pienta KJ, Sobczak ML, Asbell SO, Rajan R, Kerlin KJ, Michalski JM, Sandler HM; Radiation Therapy Oncology Group Trial 9902.  Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):672-8. Epub 2008 Nov 5.

Aronowitz JN, Crook JM, Michalski JM, Sylvester JE, Merrick GS, Mawson C, Pratt D, Naidoo D, Butler WM, Karolczuk K. Inter-institutional variation of implant activity for permanent prostate brachytherapy. Brachytherapy. 2008 Oct-Dec;7(4):297-300. Epub 2008 Sep 10.

Lin LL, El Naqa I, Leonard JR, Park TS, Hollander AS, Michalski JM, Mansur DB.Long-term outcome in children treated for craniopharyngioma with and without radiotherapy.  J Neurosurg Pediatr. 2008 Feb;1(2):126-30.

Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A.
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.  J Clin Oncol. 2007 May 20;25(15):2035-41. Erratum in: J Clin Oncol. 2007 Sep 10;25(26):4153.

Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, Parliament MB, Pollack A, Markoe AM, Harms W, Sandler HM, Cox JD. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. Int J Radiat Oncol Biol Phys 56(1)2003; 192-198

Michalski J, Mutic S, Eichling J, Ahmed S N. Radiation exposure to family and household members after prostate brachytherapy. Int J Radiat Oncol Biol Phys 56(3)2003; 764-768

Michalski JM, Klein EE, Gerber R. Method to plan, administer and verify supine craniospinal irradiation. J Appl Clin Med Phys, 3(4) 2002; 310-316

Michalski JM, Winter K, Purdy JA, Wilder R, Perez CA, Roach M, Parliament M, Pollack A, Markoe A, Harms WB, Sandler H, Cox JD. Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406.
Semin Radiat Oncol 2002 Jan; 12(1 Suppl 1):75-80

Purdy JA, Michalski JM. Does the evidence support the enthusiasm over 3D conformal radiation therapy and dose escalation in the treatment of prostate cancer? Int J Radiat Oncol Biol Phys 2001 Nov 15; 51(4):867-70



For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. Michalski

Jeff Michael Michalski, MD, MBA